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INFRAPATELLAR FAT PAD VOLUME AND SIGNAL INTENSITY
ALTERATION WERE ASSOCIATED WITH KNEE OSTEOARTHRITIC
CHANGES IN PATIENTS WITH KNEE SYMPTOMATIC OSTEOARTHRITIS
J. Cai y, K. Wang y, J. Xu y, S. Zheng y, X. Yang y, C. Ding z,y. yDept. of
Rheumatology and Immunology, First Afﬁliated Hosp. of Anhui Med.
Univ., Hefei, China; zMenzies Inst. of Med. Res., Univ. of Tasmania,
Hobart, Australia
Purpose: Infrapatellar fat pad (IPFP) may play a role in the pathogenesis
of knee osteoarthritis (OA) but there is little clinical evidence to support
this. The aim of this study was to investigate the associations between
IPFP volume, signal intensity alteration and knee structures, including
cartilage volume, cartilage defects, bone marrow lesions (BMLs) and
radiographic changes in patients with knee OA. The associations
between IPFP volume and signal intensity alteration and serum levels of
interleukin 17 and adiponectin were also been studied.
Methods: 174 randomly-selected patients with knee symptomatic OA
(mean 55.5 years, range 34 to 74, female 85.6%) participated in Anhui
Osteoarthritis (AHOA) Study. T1-weighted 3D-SPGR magnetic reso-
nance imaging (MRI) was used to measure the IPFP volume and knee
cartilage volume. T2-weighted fat suppressed fast spin echo MRI was
utilized to assess knee cartilage defects, bone marrow lesions and IPFP
signal intensity changes. Radiographic knee joint space narrowing and
osteophytes were assessed using the Osteoarthritis Research Society
International atlas. Serum interleukin-17 and adiponectin levels were
measured using ELISA.
Results: After adjustment for potential confounders, IPFP volume was
signiﬁcantly and positively associated with knee tibial and patellar
cartilage volume (all p<0.05). There were apparently negative associa-
tions between IPFP volume and cartilage defects at medial tibial (OR:
0.91, 95%CI 0.84 to 0.98), lateral tibial (OR: 0.90, 95%CI 0.83 to 0.97),
medial femoral (OR: 0.88, 95%CI 0.81 to 0.95), lateral femoral (OR: 0.89,
95%CI 0.82 to 0.97) and patellar (OR: 0.90, 95%CI 0.83 to 0.97) sites.
Similarly there were signiﬁcant and negative associations between IPFP
volume and bone marrow lesions at lateral tibial (OR: 0.88, 95%CI 0.80
to 0.98) and medial femoral (OR: 0.91, 95%CI 0.83 to 0.99) sites. IPFP
volume was also signiﬁcantly associated with lateral femoral osteo-
phytes (OR: 0.78, 95%CI 0.69 to 0.89). Furthermore, IL-17 was negatively
associated with IPFP volume (b: -0.27, 95%CI:-0.46 to -0.08).IPFP signal
intensity alteration was signiﬁcantly associated with lateral tibiofe-
moral cartilage defect (OR: 1.54, 95% CI: 1.04 to 2.27) and bone marrow
lesions at lateral (OR: 1.60, 95% CI: 1.09 to 2.36) and medial (OR: 1.51,
95% CI: 1.03 to 2.21) tibiofemoral compartment. The associations of IPFP
signal intensity alterationwith lateral (OR: 1.47, 95% CI: 1.00 to 2.16) and
medial (OR: 1.69, 95% CI: 1.15 to 2.47) femoral osteophytes were sig-
niﬁcant. There were distinctly positive associations between IPFP signal
intensity alteration and medial tibiofemoral cartilage defects, and lat-
eral and medial tibial osteophytes, but these did not reach statistically
signiﬁcance. Furthermore, there was a negative association between
IPFP signal intensity alteration and adiponectin (b: -6.32, 95%CI:-11.84
to -0.81).
Conclusions: This study was the ﬁrst to report that in patients with
knee OA, IPFP volume was negatively associated with knee cartilage
volume and positively associated with knee cartilage defects, bone
marrow lesions and osteophytes; in contrast, IPFP abnormal quality had
opposite associations. These suggest potentially a protective role of IPFP
volume and a detrimental role of IPFP abnormal quality in knee OA.
Furthermore, interleukin 17 was associated with reduced IPFP volume
but adiponectin was associated with decreased abnormal changes of
IPFP in knee OA.
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HYPERCHOLESTEROLEMIA IS A DANGER SIGNAL FOR INCREASING
RISK FOR OSTEOARTHRITIS
S. Farnaghi y, X. Mao z, R. Crawford y, Y. Xiao y, I. Prasadam y. y Inst. of
Hlth. and bioMed. Innovation, Brisbane, Australia; zOrthopedic Trauma
Res. Lab., The Second XiangYa Hosp., Central South Univ., Changsha, China
Purpose: Dyslipidaemia is associatedwith increased risk for developing
osteoarthritis (OA); however, the mechanisms implicated are largely
unknown. The objectives of this study were to determine whether
hypercholesterolemia inﬂuences the severity of post-traumatic OA. For
this purpose, Apolipoprotein E knockout mice (ApoE-/-) and Wistar
rats-both strains which are known to exhibit marked dyslipidaemiawith elevated circulating cholesterol and triglyceride levels-were sub-
jected to a high-cholesterol diet.
Methods: ApoE-/- mice andWistar rats were fed either normal chow or
a high cholesterol diet, starting when the animals were 5 weeks of age.
At 8 weeks of age, the destabilization of the medial meniscus (DMM) in
the mice and menisectomy in the rats were performed and used as an
experimental OA models. The animals were sacriﬁced, 4 and 8 weeks
after surgery, and effects of hypercholesterolemia on OA disease pro-
gression on the knee joints was evaluated by micro-CT scanning to
document changes to subchondral bone morphology. Histological sec-
tions of the medial tibial plateau, which was divided into inner, middle,
and outer regions, were prepared and scored using amodiﬁcation of the
Mankin scoring system. The cartilage thickness was also calculated, and
expression levels of aggrecan (ACAN), matrix metalloproteinase 13
(MMP13), and type X collagen (COL10) was assessed by immunohis-
tochemical staining. Moreover, expression levels of mitochondrial
damage markers such as cytochonrom C, 8 hydroxyguanosine (8OHdG)
and malondialdeyhe (MDA) were assessed by immunohistochemical
staining.
Results: At 8 weeks post-surgery, both ApoE-/- mice andWistar rats fed
with high cholesterol diet showed a number of morphological changes
compared with WT mice and rats on control diet: (1) more severe
cartilage degeneration in the medial tibial plateau and the femoral
condyle; (2) signiﬁcant reduction of ACAN expression and increased
levels of MMP-13 and COL10; (3) reduced bone volume and trabecular
thickness in medial tibial subchondral bone (Fig.1). We also observed
mitochondrial damage was elevated in the ApoE-/- mice.
Conclusions: The results from this study indicate that hyper-
cholesterolemia increases the risk of symptomatic features of OA and
the possible pathway may be via mitochondrial related cell stress.
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ACTIVIN BA DETERMINES OSTEOPHYTE SIZE IN FEMALE MICE AFTER
SURGICAL JOINT DESTABILIZATION
H. Jin, A. Freidin, J. Zarebska, B. Stott, P. Das Neves Borges, J. Saklatvala,
T.L. Vincent. The Kennedy Inst., Oxford, United Kingdom
Purpose: Activin bA is a TGFb family member that is essential for
musculoskeletal development. It is strongly regulated upon cartilage
injury in vitro (Chong et al, 2003) and surgical joint destabilization in
vivo (Burleigh et al, 2012) and is differentially regulated in the secre-
tome of human OA versus normal cartilage (Hermansson et al, 2007).
We sought to determine its role in murine disease by inducing OA in a
conditional activin bA (Act) knockout mouse.
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A297Methods: Actﬂ/ﬂ mice were crossed with a ubiquitously expressed
inducible Cre recombinase line (UbiCreERT2). Male and female mice
homozygous for the ﬂoxed allele and positive for Cre recombinase were
treated with tamoxifen at 8 weeks of age to induce deletion of the gene
in all tissues. Actﬂ/ﬂmice (without Cre) were used as negative controls.
OA was induced by destabilization of the medial meniscus. 8 weeks
following surgery joints were taken for microCT analysis to measure
epiphyseal volume according to our previously published method (Das
Neves Borges et al, 2014) and serial histology for assessment of cartilage
degradation.
Results: No overt deleterious effect of global post natal activin bA
deletion was observed. Knockout mice were noted to have delayed hair
regrowth following shaving (prior to surgery). Cartilage degradation
scores showed a trend towards being lower in knockout compared with
wild type animals although this did not reach statistical signiﬁcance.
Epiphyseal volume, a validated measure of osteophyte size, was sig-
niﬁcantly reduced in female, but not male, knockout mice. By histology,
osteophytes were present in female knockout mice but were very small
compared with male knockout animals or the wild type controls.
Conclusions: We have uncovered a novel role for activin bA in the
development of osteophytes following joint destabilization that is
restricted to female mice. Although there was a trend towards reduced
cartilage degradation scores in knockout animals, these did not reach
signiﬁcance.
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IGF-II INHIBITS PROMOTES CARTILAGE INTEGRITY IN
EXPERIMENTAL OSTEOARTHRITIS AND IL-1b-INDUCED CATABOLIC
ACTIVITY IN CHONDROCYTES
L. Zeng y, T. Uchimura y, A. Foote y, E. Matzkin z, E. Smith z. y Tufts Univ.
Sch. of Med., Boston, MA, USA; z Tufts Med. Ctr., Boston, MA, USA
Purpose: The goal of this study was to investigate the effect of IGF-II on
chondrocyte catabolic gene expression under pro-inﬂammatory cyto-
kine IL-1b treatment and on cartilage matrix levels in OA.
Methods: IN VITRO: Normal human articular chondrocytes (Lonza)
were cultured in the presence or absence of IL-1b or lentiviral hIGF-II or
GFP, and subjected to RT-PCR and Western blot analysis. IN VIVO: CD1
mice were subjected to DMM (destabilization of medial meniscus)
surgery. Lenti-IGF-II or GFP were intraarticularly injected at 1 and 2
weeks post DMM or sham surgery (6 mice/treatment). Safranin O
staining and Immunohistochemistry (IHC) were performed on sec-
tioned knees and scored by Image J and the OARSI scoring system. EX
VIVO: human OA cartilage slices were cultured in the presence of IGF-II
(10ng/ml) for 3 weeks and matrix level was analyzed by IHC and
safranin/O staining. Data are reported asmean ± standard deviation. For
parametric data, one-way analysis of variance followed by post-hoc
Tukey test was used. For nonparametric data (OARSI scores), we used
Kruskal-Wallis test followed by Mann-Whitney U test with Bonferroni
correction. P-values of <0.05 were considered signiﬁcant.
Results: To ascertain IGF expression in OA cartilage, we performed RT-
qPCR analysis using cartilage specimens obtained from the tibial pla-
teaus of a cadaveric donor and three OA patients undergone total knee
replacement surgery. We found that the expression of IGF-II, but not
IGF-I, was reduced in OA cartilage, while IL-1b and MMP13 were
increased in OA (Data not shown). We then tested whether IGF-II could
antagonize IL-1b activity in primary human articular chondrocytes, and
found that co-treatment of IL-1b with IGF-II restored Col-II and Col-IX
expression and inhibited Col-I, MMPs and iNOS induction (Fig. 1A).
Furthermore, treatment of IL-1b with IGF-II signiﬁcantly inhibited NF-
kB nuclear localization and IkBa degradation (Fig. 1B), as well as NFATc2
nuclear localization (data not shown). As phospholipase C (PLC) has
been reported to act downstream of IGF-I and IGF-II in chondrocytes,
we used a PLC inhibitor U73122, and found that IGF-II no longer pre-
vented IL-1b-induced MMP13 expression upon U73122 treatment. In
contrast, an inactive analog of PLC inhibitor, U73343, could not prevent
IGF-II from inhibiting MMP13 expression (Fig. 1C), suggesting that PLC
mediates IGF-II activity with this respect.
To determine the effect of IGF-II on articular cartilage in OA in vivo, we
utilized the DMMmousemodel, wherewe found IGF-II expression to be
decreased in the DMM knee joint as compared to the sham (Fig. 2A). We
then ectopically expressed IGF-II in mouse OA joints through intra-
articular injection of lentiviruses encoding IGF-II or GFP (control) at 1
and 2 weeks after the surgery. The efﬁciency of viral transduction was
assessed by IHC (data not shown), and joint integrity was analyzed bySafranin O staining. No signiﬁcant differences were observed between
lentiviral-IGF-II or GFP treated sham knees. However, lentiviral-IGF-II
injected DMM knee joints retained more Safranin O staining and had
smaller osteophyte formation compared to DMM joints injected with
the GFP virus (Fig. 2B and 2C). Furthermore, ectopic IGF-II expression
signiﬁcantly reduced MMP13 and NFkB (p65) expression in the DMM
knee joints (Fig. 2C and data not shown). Consistent with the mouse
data, we also found that IGF-II led to stronger safranin/O staining and
higher levels of Col-II expression, as well as reduced levels of MMP13
expression in human OA cartilage explants (Fig. 2D). Although it is
unclear whether IGF-I has a similar activity as IGF-II in OA, explant
cultures using IGF-II deﬁcient mouse metatarsal bones indicated that
IGF-II, but not IGF-I, could rescue IL-1b-mediated cartilage matrix
damage, suggesting of a functional difference between the two growth
factors (data not shown).
Conclusions: 1. IGF-II inhibits IL-1b-induced matrix gene reduction and
NF-kB and NFAT activation in human articular chondrocytes in vitro,
and its activity is mediated by PLC.
